• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

DMTs and vaccine response in MS: the evidence to date

July 27, 2021  

COVID vaccination and anti-CD20s – an update

June 28, 2021  

SARS-CoV-2 variants – an update

June 16, 2021  

COVID vaccine interchangeability – what is the evidence?

June 8, 2021  

COVID-19 mortality in MS patients: a systematic review

June 1, 2021  

Slide deck: COVID-19 – Epidemiology in Canada (May 17, 2021)

May 17, 2021  

Variable vaccine efficacy against CoV-2 variants

May 11, 2021  

mRNA vaccines preferred: new NACI recommendation

May 5, 2021  

Thrombotic risk and COVID-19 vaccines: new data and disputes

April 29, 2021  

COVID variants: is one dose better than nothing?

April 26, 2021  
Previous
1
2
3
4
5
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • ECTRIMS update on ofatumumab posted on October 11, 2024
  • Long-acting injectable aripiprazole approved in Canada posted on August 13, 2014
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions